Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 430M | 381M | 385M | 476M | 325M | 351M |
| Cost of revenue | 107M | 106M | 110M | 102M | 97M | 97M |
| Gross profit | 323M | 275M | 275M | 373M | 228M | 254M |
| Research and development | 82M | 79M | 79M | 74M | 74M | 75M |
| Selling, general and administrative | 49M | 42M | 32M | 34M | 36M | 25M |
| Operating expenses | 286M | 261M | 258M | 246M | 240M | 241M |
| Operating income | 37M | 14M | 17M | 127M | −12M | 13M |
| Pre-tax income | 40M | 24M | 25M | 126M | −12M | 15M |
| Income tax | 7M | −19M | −5M | 41M | 3M | 9M |
| Net income | 33M | 43M | 30M | 85M | −14M | 7M |
| Earnings per share | 0.19 | 0.25 | 0.18 | 0.99 | −0.08 | 0.04 |
| Earnings per share, diluted | 0.18 | 0.24 | 0.17 | 0.91 | −0.08 | 0.04 |
| Weighted average shares | 169M | 171M | 171M | 86M | 171M | 170M |
| Weighted average shares, diluted | 179M | 184M | 182M | 94M | 171M | 177M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 270M | 212M | 149M | 202M | 231M | 337M | 288M | 258M |
| Short-term investments | 204M | 213M | 203M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 212M | — | — | 204M | — | — |
| Depreciation and amortisation | 3M | — | — | 3M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 210M |
| 141M |
| 403M |
| 415M |
| 407M |
| Receivables | 174M | 265M | 161M | 156M | 203M | 305M | 174M | 166M |
| Current assets | 904M | 978M | 812M | 846M | 846M | 1.33B | 1.12B | 1.07B |
| Goodwill | 81M | 82M | 81M | 82M | 81M | 81M | 82M | 81M |
| Total assets | 1.55B | 1.63B | 1.29B | 1.32B | 1.32B | 1.77B | 1.58B | 1.54B |
| Current liabilities | 743M | 738M | 597M | 600M | 609M | 1.09B | 1.02B | 1.02B |
| Total liabilities | 845M | 844M | 696M | 700M | 711M | 1.18B | 1.11B | 1.10B |
| Equity | 706M | 787M | 597M | 625M | 611M | 585M | 473M | 435M |
| Shares outstanding | 169M | 170M | 171M | 171M | 86M | 172M | 86M | 85M |
| Shares issued | 169M | 170M | 171M | 171M | 86M | 172M | 86M | 85M |
| — |
| — |
| Share-based compensation | 46M | 43M | 37M | 41M | 37M | 36M |
| Capital expenditure | 6M | — | — | 2M | — | — |
| Investing cash flow | 3M | — | — | 262M | — | — |
| Dividends paid | 5M | — | — | 3M | — | — |
| Share buybacks | 167M | — | — | 117M | — | — |
| Financing cash flow | −154M | — | — | −576M | — | — |